Trial intelligence / Profile preview

Pulmonary protective effect of aprotinin in cardiac surgery

2006-004866-14Phase 4Completed

Sponsor
Taysha Gene Therapies
Start
Sep 2006
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4 trial of aprotinin in coronary arteriosclerosis, sponsored by Taysha Gene Therapies. Started Sep 2006; status: completed.

02

Drugs

aprotinin
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2006-004866-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004866-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call